O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving drugs in different ways may
kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of O6-benzylguanine and implanted
carmustine wafers in treating patients who have recurrent malignant glioma.